United States · FDA National Drug Code directory
Acyclovir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-3222_5a0a03d2-10ed-caa9-e063-6294a90a98e0
- Product NDC
- 68071-3222
- Form
- TABLET
- Composition / generic term
- Acyclovir
- Labeler
- NuCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131129
- Source listing expiry
- 20271231
Source-listed ingredients
- ACYCLOVIR — 800 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 50 TABLET in 1 BOTTLE (68071-3222-0) · 68071-3222-0
- 21 TABLET in 1 BOTTLE (68071-3222-1) · 68071-3222-1
- 25 TABLET in 1 BOTTLE (68071-3222-2) · 68071-3222-2
- 30 TABLET in 1 BOTTLE (68071-3222-3) · 68071-3222-3
- 14 TABLET in 1 BOTTLE (68071-3222-4) · 68071-3222-4
- 35 TABLET in 1 BOTTLE (68071-3222-5) · 68071-3222-5
- 40 TABLET in 1 BOTTLE (68071-3222-6) · 68071-3222-6
- 15 TABLET in 1 BOTTLE (68071-3222-7) · 68071-3222-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →